Prmt5 inhibition restarts a pro‐apoptotic program and creates vulnerability to combination treatment with bcl‐2 inhibitor venetoclax in mantle cell lymphoma F Brown,I Hwang,S Sloan,C Hinterschied,J Helmig‐Mason, M Long, Y Youssef,W Chan,A Prouty,J Chung, Y Zhang,S Chen‐Kiang, M DiLiberto,O Elemento,L Sehgal,L Alinari,P Scherle,K Vaddi,R Lapalombella,J Paik,R. A BaiocchiHematological Oncology（2021）引用 0|浏览10暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
